These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 8855830)
1. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo. Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830 [TBL] [Abstract][Full Text] [Related]
2. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo. Roger P; Auclair J; Drain P J Diabetes Complications; 1999; 13(2):62-7. PubMed ID: 10432168 [TBL] [Abstract][Full Text] [Related]
3. Added benfluorex in obese insulin-requiring type 2 diabetes. Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010 [TBL] [Abstract][Full Text] [Related]
4. Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients. Bianchi R; Bongers V; Bravenboer B; Erkelens DW Diabetes Care; 1993 Apr; 16(4):557-9. PubMed ID: 8462377 [TBL] [Abstract][Full Text] [Related]
6. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors. Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448 [TBL] [Abstract][Full Text] [Related]
7. Benfluorex and blood glucose control in non insulin-dependent diabetic patients. Cavallo-Perin P; Estivi P; Boine L; Galletti R; Pacini G; Cobelli C; Pagano G J Endocrinol Invest; 1991 Feb; 14(2):109-13. PubMed ID: 2061566 [TBL] [Abstract][Full Text] [Related]
8. Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Del Prato S; Erkelens DW; Leutenegger M Acta Diabetol; 2003 Mar; 40(1):20-7. PubMed ID: 12682825 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone. Velussi M; Monte AD; Cernigoi AM J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014 [TBL] [Abstract][Full Text] [Related]
10. Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Fujioka K; Seaton TB; Rowe E; Jelinek CA; Raskin P; Lebovitz HE; Weinstein SP; Diabetes Obes Metab; 2000 Jun; 2(3):175-87. PubMed ID: 11220553 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic benefit of benfluorex in type II diabetic patients treated with sulfonylureas. Stucci N; de Gregoris P; Lavielle R; Tomasi F J Diabetes Complications; 1996; 10(5):267-73. PubMed ID: 8887015 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
13. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients. Halpern A; Mancini MC; Suplicy H; Zanella MT; Repetto G; Gross J; Jadzinsky M; Barranco J; Aschner P; Ramirez L; Matos AG Diabetes Obes Metab; 2003 May; 5(3):180-8. PubMed ID: 12681025 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525 [TBL] [Abstract][Full Text] [Related]
15. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine. Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus. Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Cusi K; Cunningham GR; Comstock JP Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of hypoglycemic action of benfluorex]. Vigili de Kreutzenberg S; Riccio A; Dorella M; Da Tos V; Del Prato S Presse Med; 1992 Sep; 21(28):1340-3. PubMed ID: 1438104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]